Skip to main content
SpringerLink
Log in

Hohe Therapiesicherheit, vielfältige Einsatzmöglichkeiten und neue Entwicklungen

Topische Kortikosteroide in der dermatologischen Praxis

  • Fortbildung
  • Published:
hautnah dermatologie Aims and scope

Kortikosteroide sind das alltägliche pharmazeutische Standardwerkzeug in der Hand des Dermatologen. Es wäre aber ein Fehler zu glauben, dass es deshalb in diesem Bereich weder Fortschritte noch aktuelle evidenzbasierte Erkenntnisse gibt.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bernard P, Charneux J. Bullous pemphigoid: a review. Ann Dermatol Venereol 2011; 138: 173–181

    Article  CAS  PubMed  Google Scholar 

  2. Berth-Jones J, Damstra RJ, Golsch S et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ 2003; 326: 1367

    Article  CAS  PubMed  Google Scholar 

  3. Braun-Falco O, Plewig G Morphologisches Bild von Hauterscheinungen und geeignete Grundlagen für die Behandlung. Springer, Berlin, Heidelberg, New York 1984

    Google Scholar 

  4. Decani S et al. Iatrogenic Cushing’s syndrome and topical steroid therapy: case series and review of the literature. J Dermatol Treat 2013 Feb 3

    Google Scholar 

  5. Fricke U. Dermatika. in: S. Schwabe U, Paffrath D (Hrsg.) Arzneiverordnungsreport 2013. Springer, Heidelberg, 2013

    Google Scholar 

  6. Hanifin J, Gupta AK, Rajjagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopid dermatitis. Br J Dermatol 2002; 147: 528–537

    Article  CAS  PubMed  Google Scholar 

  7. Jensen JM, Scherer A, Wanke C et al. Gene expression is differently affected by pimecrolimus and betamethasone in lesional skin of atopic dermatitis. Allergy 2012; 67: 413–423

    Article  CAS  PubMed  Google Scholar 

  8. Korting HC, Schöllmann C. Topical fluticasone propionate: intervention and maintenance treatment options for atopic dermatitis based on a high therapeutic index. J Eur Acad Dermatol Venereol 2012; 26: 133–140

    Article  CAS  PubMed  Google Scholar 

  9. Lee YB, Park HJ, Kwon MJ, Jeong SK, Cho SH. Beneficial effects of pseudoceramide-containing physiologic lipid mixture as a vehicle for topical steroids. Eur J Dermatol 2011; 21: 710–716

    CAS  PubMed  Google Scholar 

  10. Leitlinie „Therapie der Psoriasis vulgaris“. AWMF Registriernummer 013-001. Klassifikation S3. Stand: 23.02.2011 http://www.awmf.org/leitlinien/detail/II/013-001.html

  11. Luger T et al. Topical skin therapy with glucocorticoids - the therapeutic index. J Dtsch Dermatol Ges 2004; 2629–2634

    Google Scholar 

  12. Niedner R. Kortikoide in der Dermatologie. Uni-Med, Bremen 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Renatastraße 72, 80639, München, Deutschland

    Dietrich Abeck (Gemeinschaftspraxis für Dermatologie)

Authors
  1. Dietrich Abeck
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dietrich Abeck.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abeck, D. Hohe Therapiesicherheit, vielfältige Einsatzmöglichkeiten und neue Entwicklungen. hautnah dermatologie 30, 24–28 (2014). https://doi.org/10.1007/s15012-014-0021-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15012-014-0021-7

Search

Navigation